Evidence map›Paper›PMID 38130369›Full record

ArticleJournal of vascular surgery cases and innovative techniques2024

Early experience with the Gore TAG thoracic branch endoprosthesis for treatment of acute aortic pathology.

Kathryn DiLosa, Cara Pozolo, Thomas Heafner, Misty Humphries, Mimmie Kwong, Steven Maximus

Open access · goldAbstract read
In one paragraph

Article in Journal of vascular surgery cases and innovative techniques, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Initial Post-Commercialization Experience Using a Thoracic Branch Endoprosthesis: Broad Application to Real-World Patients.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2026
    Article
  7. An Initial Single-Center European Experience with the Gore Thoracic Branch Endoprosthesis.Interdisciplinary cardiovascular and thoracic surgery · 2026
    Article
  8. Article
  9. Article
  10. Endovascular repair of two acute type A aortic dissections with Gore thoracic branch endoprosthesis.Journal of vascular surgery cases and innovative techniques · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Anesthetic Considerations for Endovascular Repair of the Thoracic Aorta.Seminars in cardiothoracic and vascular anesthesia · 2025
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kathryn DiLosaDivision of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
Cara PozoloDivision of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
Thomas HeafnerDivision of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
Misty HumphriesDivision of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
Mimmie KwongDivision of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
Steven MaximusDivision of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
University of California Davis Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Gore TAG thoracic branch endoprosthesis (TBE) is the first Food and Drug Administration-approved device for zone 2 thoracic endovascular aortic repair, allowing for graft placement proximal to the left subclavian artery origin and maintaining vessel patency through a side branch. We describe our experience with the Gore TBE device in 20 patients for acute indications, including blunt thoracic aortic injuries, complicated dissections, and ruptured aneurysms. Technical success, with exclusion of pathology and left subclavian patency, was 100% without major complications within 30 days. Our early Gore TBE device experience demonstrates safe use in acute aortic pathology without an increased risk of complications.

Indexed as

Aortic transectionBranched endograftThoracic endovascular aortic repair

Identifiers

PMID38130369
PMCPMC10731599
OpenAlexW4388249305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.